Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Gross Margin: 2009-2024

Historic Gross Margin for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to 89.24%.

  • UNITED THERAPEUTICS's Gross Margin fell 152.00% to 87.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 116.47%, marking a year-over-year increase of 2753.00%. This contributed to the annual value of 89.24% for FY2024, which is 30.00% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Gross Margin of 89.24% as of FY2024, which was up 0.34% from 88.94% recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Gross Margin ranged from a high of 92.73% in FY2021 and a low of 88.94% during FY2023.
  • For the 3-year period, UNITED THERAPEUTICS's Gross Margin averaged around 90.11%, with its median value being 89.24% (2024).
  • In the last 5 years, UNITED THERAPEUTICS's Gross Margin surged by 83bps in 2020 and then plummeted by 323bps in 2023.
  • UNITED THERAPEUTICS's Gross Margin (Yearly) stood at 92.71% in 2020, then rose by 2bps to 92.73% in 2021, then tumbled by 56bps to 92.17% in 2022, then tumbled by 323bps to 88.94% in 2023, then climbed by 30bps to 89.24% in 2024.